Affiliations 

  • 1 Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Riyadh, SAU
  • 2 Obstetrics and Gynaecology, Al-Imam Abdulrahman Al-Faisal Hospital, Ministry of Health, Riyadh, SAU
  • 3 Medicine, School of Population and Global Health, The University of Melbourne, Melbourne, AUS
  • 4 Clinical Nutrition, Applied Medical Sciences, Jazan University, Jazan, SAU
Cureus, 2020 Dec 26;12(12):e12296.
PMID: 33510990 DOI: 10.7759/cureus.12296

Abstract

Coronavirus disease 2019 (COVID-19) caused by the novel severe respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic and potentially fatal disease. COVID-19 cases are on the rise globally; this also includes risk groups such as pregnant women and neonates. Herein, we report the first COVID-19 cesarean delivery case of an in vitro fertilization (IVF) pregnancy in a Saudi woman. A postdate pregnant healthy woman tested positive with COVID-19 on her 38 weeks + five days. On her 40 weeks + five days, the woman had dilation without contractions; thereby, cesarean delivery was decided. The delivery was successful, with no complications in the mother and neonate. The preferable outcomes of this case could be attributable to some factors: multidisciplinary medical management, the mother's young age, and COVID-19 infection during the late trimester.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.